Analyst Recommendations

2.00 0.11(5.80%)10/04/2024
Prelude Therapeutics Inc (PRLD)


2024: Total Recommendations Consensus
To Grade# of Recommendations
Neutral4
Buy1
Market Outperform1

5 records were shown. To view all data, Upgrade to PRO plan with only $1


Upgrades & Downgrades